Survey data show that the symptom burden of thyroid eye disease persists during the chronic phase of the disease, with most patients reporting continued low quality of life even after systemic glucocorticoid therapy or surgery.
“Although it is widely understood that thyroid eye disease has a significant burden on patients who are in the acute phase, the impact of the disease on patients who have progressed into the chronic phase is less recognized,” Kimberly P. Cockerham, MD, FACS, adjunct clinical associate professor in the department of ophthalmology, Stanford University School
Uncategorized